ALFA FinderBSE filing, BSE: 544482. Summary written from the filing by ALFA Finder's alert engine.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹67.50
- Market cap
- ₹117.6 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 6.1×Sector 54.7×
- Promoter holding
- 71.92%
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab H1 FY27 Results: Net Profit ₹7.8 Cr, Down 22.8% YoY
Star Imaging and Path Lab Ltd reported revenue from operations of ₹48.9 Cr (+8.2% YoY) and net profit of ₹7.8 Cr (-22.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · -22.8% YoY
Star Imaging and Path Lab Board Meeting Date
Star Imaging And Path Lab Ltd intimated a board meeting on 13 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. Trading window closed from 1 October 2026 to 15 November 2026.
Star Imaging and Path Lab Business Update
Star Imaging and Path Lab has been empanelled with the Municipal Corporation of Delhi to provide diagnostic services at CGHS rates.
- From
- Municipal Corporation of Delhi (MCD)
Star Imaging and Path Lab Other Announcement
Star Imaging And Path Lab Ltd has submitted its shareholding pattern for the quarter ended September 30, 2026. The filing provides details of equity shareholdings.
Star Imaging and Path Lab Annual General Meeting
Star Imaging and Path Lab Limited held its 22nd Annual General Meeting on September 29, 2026, where shareholders considered financial statements and director re-appointments.
Star Imaging and Path Lab Production Started
Star Imaging and Path Lab has commenced commercial operations of a new CT scan diagnostic facility at R G Stone Hospital in Faridabad, Haryana.
Other other announcement announcements
All →Mahalaxmi Seamless Other Announcement
Mahalaxmi Seamless says related party transaction disclosure under Regulation 23(9) does not apply for the half year ended September 2026. Company qualifies as small entity under Regulation 15(2).
HEG Advanced Materials Other Announcement
HEG Advanced Materials reported nil re-lodgement requests for physical share transfers in October 2026 under SEBI's special window. No requests were received, processed, approved or rejected.
RDB Rasayans Other Announcement
RDB Rasayans filed its quarterly IPO proceeds utilisation statement for the quarter ended September 30, 2026. It reports no deviation or variation in use of funds.
Danube Industries Other Announcement
Danube Industries Limited filed its quarterly shareholding pattern for the period ended 30 September 2026 under Regulation 31(1)(b). The filing records promoter holding of about 39.9% and public category breakdowns, with no transaction disclosed.
Aravali Securities & Finance Other Announcement
Aravali Securities discloses standalone related party transactions for the half year ended 30 September 2026. This periodic Regulation 23(9) filing reports no new transaction.
- Execution
- Half year ended 30 September 2026
National Oxygen Other Announcement
National Oxygen is exempt from Regulation 23(9) related party disclosure for half year ended September 2026. Paid-up capital and negative net worth fall below prescribed thresholds.